ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ:SPRY) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […]

Xometry, Inc. Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Xometry, Inc. ("Xometry" or "the Company") (NASDAQ:XMTR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

Investors Are Encouraged To Join The Schall Law Firm’s Inquiry Into Zoetis Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

Shareholders Are Encouraged To Join The Schall Law Firm’s Inquiry Into Duke Realty For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Duke Realty ("Duke" or "the Company") (NYSE:DRE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

Physicians Realty Trust Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Affected Investors To Take Part

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Physicians Realty Trust ("Physicians Realty Trust" or "the Company") (NYSE:DOC) for violations of the securities laws. The investigation focuses on whether the Company issued

Investors Are Invited To Join The Schall Law Firm In A Case Against Extreme Networks Inc For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

Shareholders Are Encouraged To Join The Schall Law Firm In A Case Against Stellantis N.V. For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stellantis N.V. ("Stellantis" or "the Company") (NYSE:STLA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

Symbiotic Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Symbotic Inc. ("Symbotic" or "the Company") (NASDAQ:SYM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

Ardelyx Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a category motion lawsuit against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ:ARDX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

Scroll to Top